M&A Corner
Conformis Announces Definitive Agreement to be Acquired by Restor3d for a Purchase Price of $2.27 Per Share in Cash27 Jun 2023
Personalized 3D-printed orthopedic company restor3d will acquire Conformis, a leading orthopedic company, in a definitive merger agreement. The deal, valued... Continue Reading
|
DUOS Raises $10M to Empower Older Adults to Live Independently27 Jun 2023
Digital health company DUOS has secured an additional $10 million in funding led by Primetime Partners, SJF Ventures, and CEOC’s... Continue Reading
|
Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics27 Jun 2023
Tagworks Pharmaceuticals has raised $65 million in a Series A financing round led by Ysios Capital and Gilde Healthcare, with... Continue Reading
|
AccurKardia Secures $2.7M for Clinical Grade ECG Analytics27 Jun 2023
AccurKardia, a medical AI software company based in New York, has raised $2.7 million in seed funding led by Popular... Continue Reading
|
RLI Transportation Announces Partnership with Fleet Management Firm Motive.27 Jun 2023
RLI’s transportation unit has partnered with fleet management company Motive to offer enhanced loss control resources to RLI Transportation customers.... Continue Reading
|
Integral Ad Science and Meta Expand Partnership for Facebook and Insta reels27 Jun 2023
Integral Ad Science (IAS) has extended its partnership with Meta, the parent company of Facebook and Instagram, to provide ad... Continue Reading
|
Loop Media, Orange Door Expand Content Partnership in Australia and New Zealand27 Jun 2023
Loop Media has partnered with Orange Door, expanding the content offerings of the New Zealand-based company in New Zealand and... Continue Reading
|
Lilly Aims to Boost Immuno Business with $2.4B DICE Buy27 Jun 2023
Eli Lilly is set to acquire biopharmaceutical company DICE Therapeutics for over $2 billion. The deal, expected to close in... Continue Reading
|
Vivo Infusion Acquires Specialty Infusion Centers27 Jun 2023
Vivo Infusion has acquired Specialty Infusion, expanding its reach to 55 ambulatory infusion centers across ten states. Specialty Infusion, known... Continue Reading
|
Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property27 Jun 2023
Evox Therapeutics has acquired Codiak Biosciences’ engEx-AAV™ technology platform, gaining the intellectual property rights and exclusive access to associated engineering... Continue Reading
|